Effects of therapy with beta-blocker agents on myocardial perfusion and outcome.
Mehta
Deval
D
Iskandrian
Ami E
AE
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D003324:Coronary Artery Disease / Q000150:complications / Q000000981:diagnostic imaging* / Q000188:drug therapy* / Q000401:mortality; D018572:Disease-Free Survival; D005080:Exercise Test; D005260:Female; D005500:Follow-Up Studies; D005602:France / Q000453:epidemiology; D006801:Humans; D007511:Ischemia / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000209:etiology / Q000401:mortality*; D008297:Male; D008875:Middle Aged; D019275:Radiopharmaceuticals; D016019:Survival Analysis; D015996:Survival Rate; D013793:Thallium; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods*; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D019275:Radiopharmaceuticals; C027549:thallium chloride; D013793:Thallium